Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Cadila Healthcare submits disclosures

>>

FIIs raise stake in Cadila Healthcare in Q2FY15

>>

Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets

>>

Zydus inks pact with Gilead Sciences to produce and distribute Hepatitis C drug

>>

Zydus Cadila gets USFDA nod to market Telmisartan tablets in US

>>

Cadila Healthcare trades with traction on the bourses

>>

Zydus Cadila gets USFDA’s approval to market Acyclovir Tablets

>>

Cadila Healthcare advances on receiving final approval for Potassium Citrate ER Tablets

>>

Cadila Healthcare reports 23% rise in Q1 consolidated net profit

>>

Cadila Healthcare informs about AGM

<< < 157 158 159 ...168 > >>